These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8147904

  • 1. Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity.
    Yu PH, Zuo DM, Davis BA.
    Biochem Pharmacol; 1994 Mar 15; 47(6):1055-9. PubMed ID: 8147904
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species.
    Yu PH, Zuo DM.
    Biochem Pharmacol; 1992 Jan 22; 43(2):307-12. PubMed ID: 1739419
    [Abstract] [Full Text] [Related]

  • 3. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
    Mészáros Z, Csányi A, Vallus G, Szombathy T, Karádi I, Magyar K.
    Neurobiology (Bp); 2000 Jan 22; 8(2):215-23. PubMed ID: 11061216
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase.
    Deng Y, Yu PH.
    Anal Biochem; 1999 May 15; 270(1):97-102. PubMed ID: 10328770
    [Abstract] [Full Text] [Related]

  • 5. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.
    Lyles GA.
    Int J Biochem Cell Biol; 1996 Mar 15; 28(3):259-74. PubMed ID: 8920635
    [Abstract] [Full Text] [Related]

  • 6. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
    Conklin DJ, Bhatnagar A, Cowley HR, Johnson GH, Wiechmann RJ, Sayre LM, Trent MB, Boor PJ.
    Toxicol Appl Pharmacol; 2006 Dec 15; 217(3):277-88. PubMed ID: 17095030
    [Abstract] [Full Text] [Related]

  • 7. An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase.
    Lyles GA, Fitzpatrick CM.
    J Pharm Pharmacol; 1985 May 15; 37(5):329-35. PubMed ID: 2862241
    [Abstract] [Full Text] [Related]

  • 8. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues.
    Elliott J, Callingham BA, Barrand MA.
    J Pharm Pharmacol; 1989 Jan 15; 41(1):37-41. PubMed ID: 2565962
    [Abstract] [Full Text] [Related]

  • 9. Effect of benzylamine and its metabolites on the responses of the isolated perfused mesenteric arterial bed of the rat.
    Elliott J, Callingham BA.
    J Auton Pharmacol; 1991 Oct 15; 11(5):323-35. PubMed ID: 1748692
    [Abstract] [Full Text] [Related]

  • 10. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
    Carpéné C, Abello V, Iffiú-Soltész Z, Mercier N, Fève B, Valet P.
    Pharmacol Res; 2008 Jun 15; 57(6):426-34. PubMed ID: 18539478
    [Abstract] [Full Text] [Related]

  • 11. Semicarbazide-sensitive amine oxidase activity in rat aortic cultured smooth muscle cells.
    Blicharski JR, Lyles GA.
    J Neural Transm Suppl; 1990 Jun 15; 32():337-9. PubMed ID: 2128506
    [Abstract] [Full Text] [Related]

  • 12. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
    Langford SD, Trent MB, Balakumaran A, Boor PJ.
    Toxicol Appl Pharmacol; 1999 Mar 15; 155(3):237-44. PubMed ID: 10079209
    [Abstract] [Full Text] [Related]

  • 13. Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells.
    Langford SD, Trent MB, Boor PJ.
    Cardiovasc Toxicol; 2002 Mar 15; 2(2):141-50. PubMed ID: 12271157
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds.
    Lyles GA, Marshall CM, McDonald IA, Bey P, Palfreyman MG.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2847-53. PubMed ID: 3632710
    [Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM, Wang EY, Miller A, Podar EM, Scheyhing K, Huang L, Kessler C, Gao H, Ton-Nu HT, Macdonald MT, Jones DS, Linnik MD.
    J Pharmacol Exp Ther; 2008 Feb 01; 324(2):867-75. PubMed ID: 17993604
    [Abstract] [Full Text] [Related]

  • 16. Semicarbazide-sensitive amine oxidase from the smooth muscles of dog aorta and trachea: activation by the MAO-A inhibitor clorgyline.
    Yu PH, Fang CY, Yang CM.
    J Pharm Pharmacol; 1992 Dec 01; 44(12):981-5. PubMed ID: 1361563
    [Abstract] [Full Text] [Related]

  • 17. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
    Pino R, Lyles GA.
    Vopr Med Khim; 1997 Dec 01; 43(6):537-47. PubMed ID: 9503571
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.